FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286697408> ?p ?o ?g. }

• W4286697408 abstract "Data derived from high-throughput sequencing technologies have allowed a deeper understanding of the molecular landscape of Acute Myeloid Leukemia (AML), paving the way for the development of novel therapeutic options, with a higher efficacy and a lower toxicity than conventional chemotherapy. In the antileukemia drug development scenario, ascorbic acid, a natural compound also known as Vitamin C, has emerged for its potential anti-proliferative and pro-apoptotic activities on leukemic cells. However, the role of ascorbic acid (vitamin C) in the treatment of AML has been debated for decades. Mechanistic insight into its role in many biological processes and, especially, in epigenetic regulation has provided the rationale for the use of this agent as a novel anti-leukemia therapy in AML. Acting as a co-factor for 2-oxoglutarate-dependent dioxygenases (2-OGDDs), ascorbic acid is involved in the epigenetic regulations through the control of TET (ten-eleven translocation) enzymes, epigenetic master regulators with a critical role in aberrant hematopoiesis and leukemogenesis. In line with this discovery, great interest has been emerging for the clinical testing of this drug targeting leukemia epigenome. Besides its role in epigenetics, ascorbic acid is also a pivotal regulator of many physiological processes in human, particularly in the antioxidant cellular response, being able to scavenge reactive oxygen species (ROS) to prevent DNA damage and other effects involved in cancer transformation. Thus, for this wide spectrum of biological activities, ascorbic acid possesses some pharmacologic properties attractive for anti-leukemia therapy. The present review outlines the evidence and mechanism of ascorbic acid in leukemogenesis and its therapeutic potential in AML. With the growing evidence derived from the literature on situations in which the use of ascorbate may be beneficial in vitro and in vivo, we will finally discuss how these insights could be included into the rational design of future clinical trials." @default.
• W4286697408 created "2022-07-23" @default.
• W4286697408 creator A5013839843 @default.
• W4286697408 creator A5059441718 @default.
• W4286697408 creator A5063825892 @default.
• W4286697408 creator A5071887200 @default.
• W4286697408 creator A5075052618 @default.
• W4286697408 creator A5087863588 @default.
• W4286697408 creator A5089859676 @default.
• W4286697408 date "2022-07-22" @default.
• W4286697408 modified "2023-10-08" @default.
• W4286697408 title "The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia" @default.
• W4286697408 cites W1127887176 @default.
• W4286697408 cites W1255676896 @default.
• W4286697408 cites W1489844805 @default.
• W4286697408 cites W1517698775 @default.
• W4286697408 cites W1523116059 @default.
• W4286697408 cites W1528211880 @default.
• W4286697408 cites W1573004465 @default.
• W4286697408 cites W1597966001 @default.
• W4286697408 cites W1601071056 @default.
• W4286697408 cites W1602845909 @default.
• W4286697408 cites W1923068753 @default.
• W4286697408 cites W1967026165 @default.
• W4286697408 cites W1971208758 @default.
• W4286697408 cites W1973808664 @default.
• W4286697408 cites W1974679488 @default.
• W4286697408 cites W1976844911 @default.
• W4286697408 cites W1986906359 @default.
• W4286697408 cites W1988027547 @default.
• W4286697408 cites W1989892378 @default.
• W4286697408 cites W1991346678 @default.
• W4286697408 cites W1991698857 @default.
• W4286697408 cites W1993236149 @default.
• W4286697408 cites W1997294904 @default.
• W4286697408 cites W1997453048 @default.
• W4286697408 cites W1997589561 @default.
• W4286697408 cites W1999254494 @default.
• W4286697408 cites W2000173371 @default.
• W4286697408 cites W2001094865 @default.
• W4286697408 cites W2008092267 @default.
• W4286697408 cites W2011094327 @default.
• W4286697408 cites W2014763042 @default.
• W4286697408 cites W2014892666 @default.
• W4286697408 cites W2016242388 @default.
• W4286697408 cites W2016362758 @default.
• W4286697408 cites W2016923091 @default.
• W4286697408 cites W2020423861 @default.
• W4286697408 cites W2022826738 @default.
• W4286697408 cites W2023765801 @default.
• W4286697408 cites W2023949108 @default.
• W4286697408 cites W2026900358 @default.
• W4286697408 cites W2028817794 @default.
• W4286697408 cites W2035474025 @default.
• W4286697408 cites W2038561595 @default.
• W4286697408 cites W2040031153 @default.
• W4286697408 cites W2045492720 @default.
• W4286697408 cites W2050546949 @default.
• W4286697408 cites W2056218124 @default.
• W4286697408 cites W2058618870 @default.
• W4286697408 cites W2064318320 @default.
• W4286697408 cites W2065160134 @default.
• W4286697408 cites W2065698895 @default.
• W4286697408 cites W2066129630 @default.
• W4286697408 cites W2066753416 @default.
• W4286697408 cites W2069351864 @default.
• W4286697408 cites W2069932077 @default.
• W4286697408 cites W2073470059 @default.
• W4286697408 cites W2073979766 @default.
• W4286697408 cites W2078972833 @default.
• W4286697408 cites W2082778628 @default.
• W4286697408 cites W2088489718 @default.
• W4286697408 cites W2090929626 @default.
• W4286697408 cites W2095081648 @default.
• W4286697408 cites W2097743943 @default.
• W4286697408 cites W2108664872 @default.
• W4286697408 cites W2114138419 @default.
• W4286697408 cites W2115505172 @default.
• W4286697408 cites W2119115728 @default.
• W4286697408 cites W2122139248 @default.
• W4286697408 cites W2125088132 @default.
• W4286697408 cites W2129400442 @default.
• W4286697408 cites W2133641693 @default.
• W4286697408 cites W2140035449 @default.
• W4286697408 cites W2141776504 @default.
• W4286697408 cites W2141856502 @default.
• W4286697408 cites W2144542772 @default.
• W4286697408 cites W2144625075 @default.
• W4286697408 cites W2146644275 @default.
• W4286697408 cites W2147271521 @default.
• W4286697408 cites W2152855697 @default.
• W4286697408 cites W2156057127 @default.
• W4286697408 cites W2156704937 @default.
• W4286697408 cites W2157526928 @default.
• W4286697408 cites W2157653515 @default.
• W4286697408 cites W2161713093 @default.
• W4286697408 cites W2165805414 @default.
• W4286697408 cites W2168957766 @default.
• W4286697408 cites W2169494000 @default.
• W4286697408 cites W2235898948 @default.

• next